This Is MS Multiple Sclerosis Community: Knowledge & Support
Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
This study posted in Acceleratedcure.org(from Pubmed) shows that a drug used in Japan and Korea..Ibudilast...to treat cerebrovascular disorder showed lower brain atrophy and those on higher dose had less progression after 24 months.
Have you heard of this? is it not another clue to the Vascular theory?